News - Page 7 - Psychedelic Alpha

Read more about the article Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field

Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field

Post published:December 5, 2024
Post category:Interviews Pα+

Read more about the article Psychedelic Drug Development Under Trump 2.0: Health Nominees Signal Uncertain Future

Psychedelic Drug Development Under Trump 2.0: Health Nominees Signal Uncertain Future

Post published:November 30, 2024
Post category:Analysis News Pα+

Read more about the article Q3’24 Survey: What are Psychedelics Investors Concerned About?

Q3’24 Survey: What are Psychedelics Investors Concerned About?

Post published:November 27, 2024
Post category:Analysis News Pα+

Read more about the article Interviews: Meet the Team Who Challenged the DEA on DOI and DOC

Interviews: Meet the Team Who Challenged the DEA on DOI and DOC

Post published:November 26, 2024
Post category:Analysis News

Read more about the article Q3’24 Survey: What are Psychedelics Investors Excited About?

Q3’24 Survey: What are Psychedelics Investors Excited About?

Post published:November 25, 2024
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move

Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move

Post published:November 22, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Psychedelic Investor Survey Q3 2024

Psychedelic Investor Survey Q3 2024

Post published:November 19, 2024
Post category:Analysis News

Read more about the article Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Dispatch From the DEA: DOI and DOC on Trial As Scientists Challenge Psychedelic Scheduling Bid

Post published:November 18, 2024
Post category:Analysis News

Read more about the article Pα+ Psychedelic Bulletin #180: Mass. Psychedelics Ballot Post-Mortem Begins; Cybin Commences Phase 3; CaaMTech Claims It’s Solved Functional Unblinding

Pα+ Psychedelic Bulletin #180: Mass. Psychedelics Ballot Post-Mortem Begins; Cybin Commences Phase 3; CaaMTech Claims It’s Solved Functional Unblinding

Post published:November 15, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Tripping Over Trump: Will the New Administration Embrace Psychedelic Exceptionalism or ‘Just Say No’?

Tripping Over Trump: Will the New Administration Embrace Psychedelic Exceptionalism or ‘Just Say No’?

Post published:November 14, 2024
Post category:Analysis News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.